Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2019-12-19T15:45:07Z
dc.date.available 2019-12-19T15:45:07Z
dc.date.issued 2017
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/87730
dc.description.abstract Glycerol-3-phosphate acyltransferases (GPATs) catalyze the first and rate-limiting step in the de novo glycerolipid synthesis. The GPAT2 isoform differs from the other isoforms because its expression is restricted to male germ cells and cancer cells. It has been recently reported that GPAT2 expression in mouse testis fluctuates during sexual maturation and that it is regulated by epigenetic mechanisms in combination with vitamin A derivatives. Despite progress made in this field, information about GPAT2 role in the developing male germ cells remains unclear. The aim of the present study was to confirm the hypothesis that GPAT2 is required for the normal physiology of testes and male germ cell maturation. The gene was silenced in vivo by inoculating lentiviral particles carrying the sequence of a short-hairpin RNA targeting Gpat2 mRNA into mouse testis. Histological and gene expression analysis showed impaired spermatogenesis and arrest at the pachytene stage. Defects in reproductive fitness were also observed, and the analysis of apoptosis-related gene expression demonstrated the activation of apoptosis in Gpat2-silenced germ cells. These findings indicate that GPAT2 protein is necessary for the normal development of male gonocytes, and that its absence triggers apoptotic mechanisms, thereby decreasing the number of dividing germ cells. en
dc.format.extent 3093-3107 es
dc.language en es
dc.subject Meiosis es
dc.subject Apoptosis es
dc.subject mouse es
dc.subject gene silencing es
dc.subject germ cell es
dc.subject GPAT2 es
dc.title Glycerol-3-phosphate acyltransferase 2 is essential for normal spermatogenesis en
dc.type Articulo es
sedici.identifier.other doi:10.1042/BCJ20161018 es
sedici.identifier.other eid:2-s2.0-85029360452 es
sedici.identifier.issn 0264-6021 es
sedici.creator.person García Fabiani, María Belén es
sedici.creator.person Montanaro, Mauro Aldo es
sedici.creator.person Stringa, Pablo es
sedici.creator.person Lacunza, Ezequiel es
sedici.creator.person Cattaneo, Elizabeth Renee es
sedici.creator.person Santana, Marianela es
sedici.creator.person Pellón Maisón, Magalí es
sedici.creator.person González Baró, María del Rosario es
sedici.subject.materias Ciencias Médicas es
sedici.description.fulltext true es
mods.originInfo.place Instituto de Investigaciones Bioquímicas de La Plata es
mods.originInfo.place Facultad de Ciencias Médicas es
mods.originInfo.place Centro de Investigaciones Inmunológicas Básicas y Aplicadas es
sedici.subtype Preprint es
sedici.rights.license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
sedici.rights.uri http://creativecommons.org/licenses/by-nc-sa/4.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Biochemical Journal es
sedici.relation.journalVolumeAndIssue vol. 474, no. 18 es
sedici.rights.sherpa * Color: white * Pre-print del autor: no * Post-print del autor: restricted * Versión de editor/PDF:no * Condiciones: >>On institutional repository only >>Must link to journal website >>Published source must be acknowledged >>Publisher's version/PDF no be used >>Must link to journal website with DOI >>If funding agency rules apply, authors may post their post print in subject repositories 12 months after publication >>Authors retain copyright >>Published source must be acknowledged with citation >>Publisher last reviewed on 07/09/2015 * Link a Sherpa: http://sherpa.ac.uk/romeo/issn/0264-6021/es/


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)